National News Desk

Merck executives withheld evidence about Vioxx

Posted by Staff Writer
Thursday, December 21, 2006 3:22 PM EST
Category: Major Medical
Tags: Defective Drugs, Arthritis Drugs, Vioxx / Rofecoxib

An editorial published in the December 2005 issue of the New England Journal of Medicine reveals that Vioxx maker Merck & Co. intentionally withheld documents showing that additional heart attacks were suffered during a clinical study of the recalled arthritis drug. According to the latest report, which was published by the journal's editor in chief, an executive editor and a third doctor, Merck hid heart attacks suffered by three patients in a 2000 report on the clinical study.

The editorial also alleges that Merck executives deleted other relevant data before publishing the article with the journal. The new findings call into question conclusions found in the 2000 report, which was co-authored by Merck's vice president for clinical research. The journal has asked Merck to submit a correction.

In August 2005, a Texas jury awarded more than $250 million to the wife of a 59-year-old marathon runner who died of a heart attack while taking Vioxx. The lawsuit was the first of many to go to trial. Over 4,000 Vioxx-related lawsuits are currently pending.


No Comments

Comments for this article are closed.

About the National News Desk

Our mission is to seek the complete truth and provide a full and fair account of the events and issues that surround personal safety, accident prevention, and injury recovery.  We are committed to serving the public with honesty and integrity in these efforts.

Hurt in an accident? Contact InjuryBoard.com

Subscribe to Blog Updates

Enter your email address if you would like to receive email notifications when comments are made on this post.

Email address

Subscribe

RSS Feed

Add the National News Desk to your favorite RSS reader

Add to Google Reader Add to myYahoo Add to myMSN Add to Bloglines Add to Newsgator Add to Netvibes Add to Pageflakes